Phase I Study of Mitoxantrone Hydrochloride Liposome Injection
The purpose of this study is to determine the maximum tolerated dose,the safety and effectiveness of Mitoxantrone Hydrochloride Liposome Injection.
Malignant Lymphoma
DRUG: Mitoxantrone Hydrochloride Liposome
Maximum Tolerated Dose (MTD) of Mitoxantrone Hydrochloride Liposome Injection, 4 months
Objective Response Rate, 4 months
The trial of the dose escalation method is from 18mg/m2 until the maximum tolerated dose and every 3 patient is a dose group.